Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
VIVS vs DDD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
DDD Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–1 Matrix Metrics)
DDD Overall Winner
6-Pillar Tally: VIVS 1 – 5 DDD
Matrix Metrics: VIVS 1 – 8 DDD
As of Nov 19, 2026, 3D Systems Corporation (DDD) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VIVS carries a Unified Composite Score of 36.8/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin), whereas DDD carries 57.8/100 (HOLD) at $1.48 (22.5x Forward P/E, -15.1% operating margin).
- Technical & Structure Timing Caution: VIVS is currently in a Breakdown options structure phase (RSI 75.1); meanwhile DDD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About VIVS vs DDD
VIVS
VivoSim Labs, Inc. Common Stock
$0.29
+142.92% 1D
Market Cap
$2.4M
TTM Revenue
$112,000
Forward P/E
N/M
Beta / 30D Vol
0.83β · 480% Vol
Unified Composite Score
36.8
SELL
Tech 5.0
Fund 38.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
DDD
Head-to-Head Winner
3D Systems Corporation
$1.48
+7.25% 1D
Market Cap
$250.2M
TTM Revenue
$396M
Forward P/E
22.5x
Beta / 30D Vol
3.24β · 140% Vol
Unified Composite Score
57.8
HOLD
Tech 60.0
Fund 62.0
Flow 70.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (VIVS 1 – 5 DDD)
1. Valuation Multiples
DDD
Forward P/E
N/M
22.5x
Trailing P/E
N/M
22.5x
PEG Ratio
N/M
0.85x
EV / Revenue
9.6x
0.8x
2. Growth & Scale
DDD
Revenue Growth (YoY)
-51.4%
+8.8%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$112,000
$396M
Market Cap
$2.4M
$250.2M
3. Profitability & Quality
DDD
Gross Margin
N/A
34.5%
Operating Margin
-10117.0%
-15.1%
Net Profit Margin
0.0%
-17.8%
Return on Equity (ROE)
-343.1%
-30.0%
4. Balance Sheet & Cash Flow
VIVS
Cash Generation (TTM)
-$11M EBITDA
-$48M
Cash Flow Margin
N/A
-12.3%
Net Cash / Leverage
$1.4M Net Cash
$51M Net Debt (0.58x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
DDD
Options Structure Phase
BREAKDOWN
BREAKDOWN
Current IV / %ile
N/A (N/A)
104.4% (32nd %ile)
Put/Call OI Skew
N/A
0.11x (Call-Skewed)
OBV Trend / Tech Phase
ACCUMULATION · Neutral
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
DDD
OpEx & R&D Intensity
N/A
49.6% of Rev ($196M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Biotechnology Operator
Computer Hardware Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: VIVS (1) vs DDD (8)| Institutional Metric | VIVS | DDD | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $2.4M | $250.2M | DDD | |
| Trailing P/E Ratio | N/M | 22.5x | DDD | |
| Forward P/E Ratio | N/M | 22.5x | DDD | |
| Revenue Growth (YoY) | -51.4% | +8.8% | DDD | |
| Operating Margin (TTM) | -10117.0% | -15.1% | DDD | |
| Net Profit Margin | 0.0% | -17.8% | VIVS | |
| Return on Equity (ROE) | -343.1% | -30.0% | DDD | |
| 52-Week Range Position | 5% ($0–$3) | 6% ($1–$4) | Tie | |
| Beta / 30D Volatility | 0.83β · 480% Vol | 3.24β · 140% Vol | DDD | |
| Unified Institutional Score | 36.8 / 100 (SELL) | 57.8 / 100 (HOLD) | DDD | |
| Trailing 12M Revenue (USD) | $112,000 | $396M | Scale | |
| Gross Profit Margin (TTM) | N/A | 34.5% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 9.6x EV/Rev | 0.85x PEG · 0.8x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$11M EBITDA ($1.4M Net Cash) | -$48M ($51M Net Debt (0.58x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
VIVS +115.68 pp
3M Horizon
VIVS +55.53 pp
6M Horizon
DDD +27.75 pp
1Y Horizon
DDD +58.14 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VIVS Revenue | DDD Revenue | VIVS Op. Margin | DDD Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2019 | $0M | $640M | -882.4% | -9.0% | DDD |
| FY2020 | $0M | $560M | -977.9% | -21.3% | DDD |
| FY2021 | N/A | $620M | N/A | -5.4% | DDD |
| FY2022 | $0M | $540M | -765.3% | -21.7% | DDD |
| FY2023 | $0M | $490M | -4792.2% | -83.2% | DDD |
| FY2024 | $0M | $440M | -13840.4% | -63.0% | DDD |
| FY2025 | $0M | $390M | -8761.1% | -24.8% | DDD |
| FY2026 | $0M | N/A | -8768.7% | N/A | VIVS |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
VIVS
BREAKDOWN
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
ACCUMULATION
Exact VIVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
DDD
BREAKDOWN
Current IV
104.4%
IV Percentile
32nd %ile
Put/Call OI Skew
0.11x (Call-Skewed)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact DDD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
VIVS Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
DDD Moat Profile
Cyclical / Execution-Driven Positioning
Computer Hardware Operator
OpEx & R&D Reinvestment
49.6% of Rev ($196M)
90D Engineering Disclosures
0 Published
Investor FAQ VIVS vs DDD Key Questions & Quantitative Answers
As of Nov 19, 2026, 3D Systems Corporation (DDD) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VIVS carries a Unified Composite Score of 36.8/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin), whereas DDD carries 57.8/100 (HOLD) at $1.48 (22.5x Forward P/E, -15.1% operating margin). Technical & Structure Timing Caution: VIVS is currently in a Breakdown options structure phase (RSI 75.1); meanwhile DDD is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DDD leads the Growth & Scale pillar: VIVS posts -51.4% YoY revenue growth and +0.0% YoY earnings growth on $112,000 TTM revenue (N/A gross margin, -10117.0% operating margin), compared with DDD at +8.8% YoY revenue growth and +0.0% YoY earnings growth on $396M TTM revenue (34.5% gross margin, -15.1% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), VIVS cumulative revenue shifted N/A while DDD shifted -39.1%. In operating R&D and SG&A reinvestment, VIVS deploys N/A (0 90-day corporate R&D disclosures) versus 49.6% of Rev ($196M) (0 disclosures) for DDD.
DDD screens cheaper on headline valuation multiples. VIVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.6x EV/Revenue (unreported EBITDA margin), whereas DDD trades at 22.5x Forward P/E, 22.5x Trailing P/E, 0.85x PEG, and 0.8x EV/Revenue (-12.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VIVS (-343.1% ROE) versus DDD (-30.0% ROE) capital efficiency.
In options market volatility and institutional positioning, VIVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.83β · 480% Vol realized risk). By comparison, DDD carries 104.4% implied volatility (32nd %ile, Balanced (25th–60th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.24β · 140% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
DDD vs VIVS · Reverse Pair
VIVS vs SSYS
· Sector Peer
VIVS vs PRLB
· Sector Peer
VIVS vs MTLS
· Sector Peer
DDD vs SSYS
· Sector Peer
DDD vs PRLB
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem